| 报告题目:Well-ordered mesoporous bioactive glasses for bone tissue engineering and drug delivery              报 告 人:吴成铁博士 (澳大利亚昆士兰科技大学)              报告时间:2011年12月20日(星期二)下午 15:30              报告地点:独墅湖校区907楼1445              主持人:    张克勤教授              报告摘要:The impact of bone diseases and trauma in the whole world has increased significantly in the past decades. Bioactive glasses are regarded as an important bone regeneration material due to their generally excellent osteoconductivity and osteostimulativity. A new class of bioactive glass, referred to as mesoporous bioglass (MBG), was developed seven years ago, which has highly ordered mesoporous channel structure and high specific surface area. The aim of study is (1) to investigate the in vitro and in vivo bone-formation ability of novel class of MBG; (2) to investigate the potential application of MBG for drug/growth factor delivery and bone tissue engineering. Our study has found that MBGs offer a suite of features which are important for efficient drug delivery and bone regeneration. The typical features include that: (1) they possess well ordered mesoporous channel structure and controllable nanopore size, which endows them high specific surface area and pore volume. The improved physical properties play an important role to enhance their biological behavior; (2) they have excellent in vitro and in vivo bioactivity. Particularly, they have shown the stimulatory effect to enhance in vivo bone formation, compared to non-mesoporous bioglass; and (3) they are excellent carriers for the delivery of drugs and growth factors to further improve anti-bacteria ability and stimulate the growth and differentiation of tissue cells as well as bone tissue formation.              报告人简介:吴成铁博士, 2003年3月至2006年2月在中国科学院上海硅酸盐研究所攻读博士学位。2006年2月赴澳大利亚悉尼大学生物医学工程系从事博士后研究。2007年2月获得悉尼大学特聘研究员(Vice-chancellor research fellow),并在悉尼大学从事生物材料与组织工程的研究至2009年4月。2009年4月至目前作为昆士兰科技大学研究员(Vice-chancellor research fellow)在昆士兰科技大学生物及健康研究所从事生物医用材料的研究。其中2010年2月至2011年3月在德国德累斯顿工业大学做洪堡研究员。主要从事多孔生物活性陶瓷及介孔生物活性玻璃在骨组织工程及药物/蛋白传输方面的基础研究和应用研究。在生物材料领域发表SCI 期刊论文50余篇(第一作者40篇),撰写两章英文专著(第一作者),其中在生物材料领域最有影响力的杂志Biomaterials (IF 7.882) 上发表论文10篇,Acta Biomater (IF 4.822)上发表论文11篇, J R Soc Interface (IF 4.259) 上发表论文2篇,J Biomed Mater Res A(IF 3.044)上发表论文4篇。影响因子大于3的文章共32篇,论文共被引用560余次,h指数达到15。参加国际、国内生物材料领域大会并做报告30余次。获三项中国专利及两项国际专利(PCT)授权,其中两项中国专利已经转让给生物材料公司。作为项目主持人获德国洪堡基金委员会(Alexander von Humboldt)、瑞士国际植入协会(ITI)、澳大利亚研究司(ARC discovery project)、悉尼大学(USYD)及昆士兰科技大学(QUT)等科研项目资助大约600万人民币;并获得了德国洪堡研究员、澳大利亚ARC研究员(APDI fellowship)、悉尼大学研究员及昆士兰科技大学研究员等四个荣誉研究员(Fellowship)。               |         
| (现代丝绸国家工程实验室) | 
